background
still
becom
increas
global
threat
public
health
detail
specif
characterist
need
better
understand
diseas
addit
durat
eg
averag
time
exposur
recoveri
great
valu
understand
diseas
report
far
aim
give
inform
clinic
characterist
differ
durat
identifi
potenti
risk
factor
longer
hospit
durat
retrospect
studi
enrol
patient
mean
age
year
male
laboratoryconfirm
admit
beij
youan
hospit
st
jan
th
februari
epidemiolog
clinic
radiolog
data
admiss
collect
complic
outcom
follow
th
februari
studi
endpoint
discharg
within
two
week
cox
proportionalhazard
regress
perform
identifi
risk
factor
longer
hospit
durat
patient
male
comorbid
lymphopenia
categor
sever
patient
occur
complic
end
followup
patient
discharg
home
test
neg
infect
remain
hospit
die
patient
discharg
within
day
thu
reach
studi
endpoint
includ
nonsever
patient
sever
patient
overal
cumul
probabl
endpoint
hospit
length
stay
durat
exposur
discharg
discharg
patient
day
respect
multivari
stepwis
cox
regress
model
show
bilater
pneumonia
ct
scan
shorter
time
ill
onset
admiss
sever
diseas
lymphopenia
independ
associ
longer
hospit
durat
conclus
significantli
shorter
durat
diseas
hospit
length
stay
sar
bilater
pneumonia
ct
scan
shorter
period
ill
onset
admiss
lymphopenia
sever
diseas
risk
factor
longer
hospit
durat
sinc
start
last
month
outbreak
infect
success
attract
attent
whole
world
virtu
highli
contagi
attribut
novel
coronaviru
spread
across
countriesterritori
caus
infect
case
death
th
march
number
still
rapidli
increas
moreov
threat
global
health
rapidli
increas
made
world
health
organ
declar
pandem
undoubtedli
prepared
viru
strike
necessari
critic
import
especi
countri
high
risk
rel
weaker
public
health
system
circumst
experi
contain
peer
countri
territori
comprehens
research
would
undoubtedli
help
mani
previou
studi
gener
report
epidemiolog
featur
clinic
characterist
virolog
featur
characterist
diseas
may
present
differ
among
differ
locat
time
sinc
pathogen
may
evolv
transmiss
thu
import
close
follow
chang
better
contain
manag
addit
durat
eg
averag
time
exposur
recoveri
hospit
durat
import
understand
diseas
use
prepared
respons
correctli
report
mainli
patient
includ
previou
studi
still
remain
hospit
studi
done
present
clinic
data
hospit
patient
youan
hospit
beij
china
aim
give
inform
clinic
characterist
differ
durat
incub
period
ill
onset
first
hospit
ill
onset
discharg
exposur
discharg
hospit
durat
addit
paper
also
aim
identifi
potenti
risk
factor
longer
hospit
durat
collect
retrospect
review
medic
record
compil
data
hospit
patient
laboratoryconfirm
beij
youan
hospit
beij
china
st
jan
th
feb
diagnos
accord
interim
guidanc
world
health
organ
confirm
case
defin
posit
result
realtim
reversetranscriptasepolymerasechainreact
rtpcr
assay
nasopharyng
swab
sampl
local
ethic
review
board
hospit
approv
studi
waiv
inform
consent
patient
consid
retrospect
natur
studi
epidemiolog
clinic
laboratori
radiograph
data
outcom
data
extract
electron
medic
record
detail
follow
inform
collect
demograph
exposur
medic
histori
coexist
diseas
symptom
sign
laboratori
ct
scan
find
admiss
complic
outcom
data
followup
complic
clinic
outcom
follow
th
feb
case
categor
nonsever
sever
time
admiss
acut
respiratori
distress
syndrom
ard
defin
accord
guidanc
acut
kidney
injuri
accord
kidney
diseas
improv
global
outcom
definit
durat
ill
onset
first
hospit
admiss
discharg
calcul
well
hospit
durat
hospit
length
stay
durat
exposur
ill
onset
discharg
calcul
singl
point
exposur
histori
could
provid
specif
date
current
unclear
normal
length
hospit
stay
patient
discharg
home
aliv
retrospect
averag
hospit
length
stay
discharg
patient
studi
day
thu
set
discharg
within
two
week
day
endpoint
studi
accordingli
divid
studi
patient
two
group
endpoint
shorter
hospit
durat
without
endpoint
longer
hospit
durat
fit
discharg
base
abat
fever
least
three
day
improv
evid
chest
radiographi
least
consecut
neg
pcr
assay
result
hour
apart
continu
variabl
express
mean
standard
deviat
sd
normal
distribut
data
median
interquartil
iqr
skew
data
correspondingli
twosampl
independ
ttest
mannwhitney
u
test
use
detect
differ
group
categor
variabl
describ
number
compar
test
fisher
exact
test
appropri
kaplanmei
method
use
estim
cumul
probabl
endpoint
cox
proportionalhazard
regress
model
conduct
determin
potenti
risk
factor
associ
endpoint
statist
signific
defin
p
analys
done
sa
softwar
version
epidemiolog
clinic
characterist
studi
patient
shown
tabl
patient
studi
wide
age
span
year
mean
valu
year
male
histori
exposur
wuhan
found
patient
especi
initi
stage
spread
beij
shown
figur
patient
histori
exposur
huanan
market
andor
wildlif
anim
patient
involv
famili
cluster
infect
healthcar
worker
fever
common
symptom
onset
ill
follow
cough
fatigu
digest
symptom
diarrhea
rare
two
patient
asymptomat
admiss
twentyfour
patient
present
coexist
disord
includ
hypertens
cardiovascular
diseas
diabet
among
other
patient
categor
nonsever
sever
patient
respect
patient
develop
least
one
complic
liver
dysfunct
common
one
complic
rare
compar
nonsever
patient
sever
patient
older
age
like
present
short
breath
symptom
higher
occurr
hypertens
cardiovascular
diseas
term
coexist
diseas
laboratori
radiograph
find
admiss
present
tabl
white
blood
cell
count
neutrophil
lymphocyt
proport
reduc
patient
respect
elev
countproport
blood
cell
could
also
observ
patient
signific
increas
creactiv
protein
observ
patient
patient
chest
ct
scan
time
admiss
reveal
abnorm
result
includ
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
unilater
pneumonia
bilater
pneumonia
contrast
nonsever
patient
sever
patient
show
significantli
higher
level
white
blood
cell
neutrophil
lower
level
lymphocyt
monocyt
creactiv
protein
lactat
concentr
procalcitonin
creatin
kinasemb
myoglobin
hypersensit
troponin
patient
twentythre
singl
episod
exposur
histori
could
provid
specif
date
median
interquartil
rang
incub
period
patient
day
patient
time
ill
onset
admiss
hospit
durat
day
respect
term
discharg
patient
time
ill
onset
discharg
exposur
point
discharg
avail
patient
day
respect
contrast
sever
patient
nonsever
patent
show
shorter
hospit
durat
followup
administ
patient
end
followup
patient
discharg
eight
remain
hospit
five
die
five
death
three
caus
directli
thirtysix
patient
discharg
within
day
thu
reach
studi
endpoint
includ
nonsever
patient
sever
patient
overal
cumul
probabl
endpoint
nonsever
sever
patient
cumul
probabl
respect
sever
variabl
signific
differ
patient
without
endpoint
select
univari
cox
proportionalhazard
regress
model
shown
figur
statist
signific
risk
factor
includ
multivari
stepwis
cox
regress
model
bilater
pneumonia
ct
scan
time
ill
onset
admiss
sever
diseas
lymphopenia
remain
final
display
tabl
present
studi
report
retrospect
data
hospit
patient
beij
china
discharg
home
aliv
end
followup
among
small
number
patient
wide
span
age
year
suggest
individu
age
suscept
infect
intriguingli
femal
identifi
studi
contract
previous
studi
male
report
constitut
higher
proport
patient
reveal
male
higher
express
level
receptor
thu
suscept
invas
recent
chines
center
diseas
control
prevent
present
biggest
data
confirm
case
indic
rel
even
sex
distribut
male
vs
femal
find
suggest
sex
differ
found
earli
stage
outbreak
might
coincid
exposur
differ
sex
studi
patient
histori
exposur
wuhan
especi
initi
stage
spread
beij
number
patient
reduc
time
along
reduc
number
patient
suggest
effect
quarantin
wuhan
citi
control
contain
beij
citi
countri
demonstr
recent
studi
lot
patient
got
infect
famili
cluster
emphas
import
self
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
isol
confirm
suspect
case
well
import
public
awar
campaign
educ
incub
time
report
mani
previou
studi
li
el
al
studi
first
patient
wuhan
china
report
incub
period
day
confid
interv
day
base
nation
dataset
patient
guan
et
al
report
similar
period
day
interquartil
rang
obtain
consist
result
mean
durat
day
iqr
day
longest
incub
period
studi
day
support
isol
suspect
case
durat
ill
onset
hospit
admiss
import
factor
spread
viru
infect
sooner
patient
hospit
treat
less
spread
previou
studi
report
durat
ill
onset
hospit
admiss
earli
stage
outbreak
day
present
studi
time
symptom
onset
hospit
admiss
significantli
shorter
day
iqr
day
attribut
increas
awar
public
epidem
daili
publicwid
educ
campaign
precautionari
measur
exposur
equivoc
whether
longer
durat
symptom
onset
hospit
admiss
associ
clinic
outcom
patient
huang
et
al
find
differ
durat
icu
nonicu
patient
howev
wang
et
al
investig
patient
reveal
patient
admit
icu
longer
durat
vs
day
present
studi
also
observ
longer
durat
sever
patient
versu
nonsever
patient
supplementari
file
may
attribut
longer
prehospit
durat
may
delay
treatment
thu
lead
unfavor
outcom
current
studi
report
averag
hospit
length
stay
discharg
patient
present
studi
report
averag
hospit
length
stay
day
iqr
patient
three
day
longer
wang
et
al
report
base
discharg
patient
wuhan
howev
studi
patient
incub
period
two
day
longer
studi
nevertheless
length
hospit
stay
significantli
shorter
sar
almost
one
month
indic
milder
sever
also
reveal
cumul
probabl
patient
discharg
within
two
week
nonsever
sever
patient
respect
mean
nearli
nonsever
patient
discharg
within
two
week
sinc
length
hospit
stay
relat
durat
ill
onset
hospit
admiss
durat
ill
onset
discharg
may
better
present
clinic
cours
take
incub
time
consider
whole
durat
exposur
recoveri
day
best
knowledg
might
first
descript
whole
durat
small
number
patient
singl
center
includ
studi
base
larg
sampl
size
multipl
center
warrant
confirm
find
longer
durat
diseasehospit
mean
medic
burden
especi
face
exponenti
increas
need
within
short
period
produc
transmiss
diseas
like
one
challeng
situat
address
outbreak
transmiss
diseas
might
rapidli
increas
patient
excess
exce
healthcar
capac
although
outbreak
well
control
china
mani
countri
still
face
seriou
outbreak
inform
report
present
studi
especi
durat
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
correspond
risk
factor
longer
hospit
durat
could
contribut
countri
well
prepar
redistribut
medic
resourc
flatten
curv
thu
delay
epidem
peak
studi
sever
limit
first
rel
small
number
patient
singl
center
beij
includ
obvious
length
hospit
stay
differ
across
hospit
citi
countri
would
valuabl
draw
correspond
durat
identifi
risk
factor
base
dataset
citi
nation
scale
second
could
provid
use
inform
averag
durat
ill
onset
death
limit
data
studi
third
treatment
pivot
determin
durat
diseas
howev
current
detail
data
treatment
patient
determin
influenc
treatment
durat
continu
work
futur
conclus
averag
hospit
length
stay
day
discharg
patient
averag
time
clinic
cours
day
significantli
shorter
sar
bilater
pneumonia
ct
scan
shorter
period
ill
onset
admiss
lymphopenia
sever
diseas
risk
factor
longer
hospit
durat
find
might
use
countri
territori
face
threat
well
prepar
rebal
medic
resourc
declar
compet
interest
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
categor
variabl
present
number
percentag
wbc
white
blood
cell
rbc
red
blood
cell
crp
creactiv
protein
aptt
activ
partial
thromboplastin
time
ast
aspart
aminotransferas
alt
alanin
aminotransferas
htni
hypersensit
troponin
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
